Adc Therapeutics Sa (ADCT)

Finanzdaten der Adc Therapeutics Sa-Aktie (ADCT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.69%19.25	20.85	23.06	16.43	18.84
	12.63%17.37	19.88	-	-	-
Research and Development	12.63%17.37	19.88	-	-	-
Costs And Expenses	3.11%44.66	46.10	40.98	47.40	62.99
Operating Income/Loss	0.67%-25.41	-25.25	-17.92	-30.97	-44.15
Nonoperating Income/Loss	214.58%8.85	-7.72	11.11	-10.00	-11.25
Income/Loss From Continuing Operations Before Tax	49.75%-16.57	-32.97	-6.81	-40.97	-55.39
Income Tax Expense/Benefit	-	-	-0.40	-	1.25
	49.75%-16.57	-32.97	-6.41	-40.97	-56.65
Attributable To Parent	49.75%-16.57	-32.97	-6.41	-40.97	-56.65
Basic Average Shares	0.57%155.02	154.14	7.83	136.45	113.74
Diluted Average Shares	0.57%155.02	154.14	7.83	136.45	113.74
Basic Earnings Per Share	47.62%-0.11	-0.21	0.02	-0.30	-0.50
Diluted Earnings Per Share	47.62%-0.11	-0.21	0.02	-0.30	-0.50